Therapeutic patents
Abstracts provide you with the first source of intelligence about your competitors' R&D programs.

Scientific meetings
Unique intelligence reports provide you with a primary source of first data on new drugs.

Scientific literature
Monitored directly or via abstracting databases to provide you with references on drug R&D.

Industry news
Filtered from daily newswires and key business sources to provide you with current company and drug news.

Company communications
Used to validate the information and provide you with levels of confidence for the data.

 Next page